Pharmacokinetic Properties of Single and Multiple Doses of Ertugliflozin, a Selective Inhibitor of SGLT2, in Healthy Chinese Subjects

Ertugliflozin, a sodium‐glucose cotransporter 2 inhibitor for the treatment of type 2 diabetes mellitus, prevents renal glucose reabsorption resulting in urinary glucose excretion. This open‐label, parallel cohort, randomized study conducted in healthy Chinese adults residing in China assessed the p...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Clin Pharmacol Drug Dev
Hoofdauteurs: Li, Yinhua, Mu, Yuting, Shi, Haihong, Liang, Yali, Liu, Zeyuan, Matschke, Kyle, Hickman, Anne, Krishna, Rajesh, Sahasrabudhe, Vaishali
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: John Wiley and Sons Inc. 2019
Onderwerpen:
Articles
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7003779/
https://ncbi.nlm.nih.gov/pubmed/30934166
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cpdd.686
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items